125 related articles for article (PubMed ID: 24462709)
1. Platelet-derived growth factor-stimulated versican synthesis but not glycosaminoglycan elongation in vascular smooth muscle is mediated via Akt phosphorylation.
Osman N; Getachew R; Thach L; Wang H; Su X; Zheng W; Little PJ
Cell Signal; 2014 May; 26(5):912-6. PubMed ID: 24462709
[TBL] [Abstract][Full Text] [Related]
2. PDGF beta-receptor kinase activity and ERK1/2 mediate glycosaminoglycan elongation on biglycan and increases binding to LDL.
Getachew R; Ballinger ML; Burch ML; Reid JJ; Khachigian LM; Wight TN; Little PJ; Osman N
Endocrinology; 2010 Sep; 151(9):4356-67. PubMed ID: 20610572
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of Ki11502 as a potent inhibitor of PDGF beta receptor-mediated proteoglycan synthesis in vascular smooth muscle cells.
Getachew R; Ballinger ML; Burch ML; Little PJ; Osman N
Eur J Pharmacol; 2010 Jan; 626(2-3):186-92. PubMed ID: 19818754
[TBL] [Abstract][Full Text] [Related]
4. Genistein inhibits PDGF-stimulated proteoglycan synthesis in vascular smooth muscle without blocking PDGFβ receptor phosphorylation.
Little PJ; Getachew R; Rezaei HB; Sanchez-Guerrero E; Khachigian LM; Wang H; Liao S; Zheng W; Ballinger ML; Osman N
Arch Biochem Biophys; 2012 Sep; 525(1):25-31. PubMed ID: 22683649
[TBL] [Abstract][Full Text] [Related]
5. TGF-β stimulates biglycan core protein synthesis but not glycosaminoglycan chain elongation via Akt phosphorylation in vascular smooth muscle.
Osman N; Getachew R; Burch M; Lancaster G; Wang R; Wang H; Zheng W; Little PJ
Growth Factors; 2011 Oct; 29(5):203-10. PubMed ID: 21913799
[TBL] [Abstract][Full Text] [Related]
6. (S)-[6]-Gingerol inhibits TGF-β-stimulated biglycan synthesis but not glycosaminoglycan hyperelongation in human vascular smooth muscle cells.
Kamato D; Babaahmadi Rezaei H; Getachew R; Thach L; Guidone D; Osman N; Roufogalis B; Duke CC; Tran VH; Zheng W; Little PJ
J Pharm Pharmacol; 2013 Jul; 65(7):1026-36. PubMed ID: 23738730
[TBL] [Abstract][Full Text] [Related]
7. Genistein selectively inhibits platelet-derived growth factor-stimulated versican biosynthesis in monkey arterial smooth muscle cells.
Schönherr E; Kinsella MG; Wight TN
Arch Biochem Biophys; 1997 Mar; 339(2):353-61. PubMed ID: 9056268
[TBL] [Abstract][Full Text] [Related]
8. Suramin inhibits PDGF-stimulated receptor phosphorylation, proteoglycan synthesis and glycosaminoglycan hyperelongation in human vascular smooth muscle cells.
Little PJ; Rostam MA; Piva TJ; Getachew R; Kamato D; Guidone D; Ballinger ML; Zheng W; Osman N
J Pharm Pharmacol; 2013 Jul; 65(7):1055-63. PubMed ID: 23738733
[TBL] [Abstract][Full Text] [Related]
9. Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo.
Ballinger ML; Osman N; Hashimura K; de Haan JB; Jandeleit-Dahm K; Allen T; Tannock LR; Rutledge JC; Little PJ
J Cell Mol Med; 2010 Jun; 14(6B):1408-18. PubMed ID: 19754668
[TBL] [Abstract][Full Text] [Related]
10. Platelet-derived growth factor differentially regulates the expression and post-translational modification of versican by arterial smooth muscle cells through distinct protein kinase C and extracellular signal-regulated kinase pathways.
Cardoso LE; Little PJ; Ballinger ML; Chan CK; Braun KR; Potter-Perigo S; Bornfeldt KE; Kinsella MG; Wight TN
J Biol Chem; 2010 Mar; 285(10):6987-95. PubMed ID: 20042606
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of imatinib on PDGF-induced proliferation and PDGF receptor signaling in human arterial and venous smooth muscle cells.
Li L; Blumenthal DK; Masaki T; Terry CM; Cheung AK
J Cell Biochem; 2006 Dec; 99(6):1553-63. PubMed ID: 16817200
[TBL] [Abstract][Full Text] [Related]
12. Pyrido-pyrimidine derivative CYC10424 inhibits glycosaminoglycan changes on vascular smooth muscle-derived proteoglycans and reduces lipoprotein binding.
Ballinger ML; Osman N; Wilks AF; Su S; Burns CJ; Bu X; Little PJ
J Cardiovasc Pharmacol; 2008 Nov; 52(5):403-12. PubMed ID: 19033819
[TBL] [Abstract][Full Text] [Related]
13. Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation.
Yang X; Thomas DP; Zhang X; Culver BW; Alexander BM; Murdoch WJ; Rao MN; Tulis DA; Ren J; Sreejayan N
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):85-90. PubMed ID: 16239599
[TBL] [Abstract][Full Text] [Related]
14. Thrombin regulates vascular smooth muscle cell proteoglycan synthesis via PAR-1 and multiple downstream signalling pathways.
Ivey ME; Little PJ
Thromb Res; 2008; 123(2):288-97. PubMed ID: 18571697
[TBL] [Abstract][Full Text] [Related]
15. Growth factor-mediated hyper-elongation of glycosaminoglycan chains on biglycan requires transcription and translation.
Yang SN; Burch ML; Getachew R; Ballinger ML; Osman N; Little PJ
Arch Physiol Biochem; 2009 Jul; 115(3):147-54. PubMed ID: 19580379
[TBL] [Abstract][Full Text] [Related]
16. Binding of platelet-derived growth factor and low density lipoproteins to glycosaminoglycan species produced by human arterial smooth muscle cells.
Fager G; Camejo G; Olsson U; Ostergren-Lundén G; Lustig F; Bondjers G
J Cell Physiol; 1995 May; 163(2):380-92. PubMed ID: 7706380
[TBL] [Abstract][Full Text] [Related]
17. PDGF-induced glycosaminoglycan synthesis is mediated via phosphatidylinositol 3-kinase.
Liu J; Fitzli D; Liu M; Tseu I; Caniggia I; Rotin D; Post M
Am J Physiol; 1998 May; 274(5):L702-13. PubMed ID: 9612285
[TBL] [Abstract][Full Text] [Related]
18. Flavopiridol Inhibits TGF-
Rostam MA; Shajimoon A; Kamato D; Mitra P; Piva TJ; Getachew R; Cao Y; Zheng W; Osman N; Little PJ
J Pharmacol Exp Ther; 2018 Apr; 365(1):156-164. PubMed ID: 29438988
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-1 stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by endothelin receptor transactivation of the transforming growth factor-[beta] type I receptor.
Little PJ; Burch ML; Getachew R; Al-aryahi S; Osman N
J Cardiovasc Pharmacol; 2010 Oct; 56(4):360-8. PubMed ID: 20625315
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the atherogenic properties of vascular smooth muscle proteoglycans by oral anti-hyperglycemic agents.
de Dios ST; Frontanilla KV; Nigro J; Ballinger ML; Ivey ME; Cawson EA; Little PJ
J Diabetes Complications; 2007; 21(2):108-17. PubMed ID: 17331859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
